Related references
Note: Only part of the references are listed.Extended results of the Alzheimer's disease anti-inflammatory prevention trial
John C. Breitner et al.
ALZHEIMERS & DEMENTIA (2011)
Signaling via the prostaglandin E2 receptor EP4 exerts neuronal and vascular protection in a mouse model of cerebral ischemia
Xibin Liang et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Regulation of Calcium Channels and Exocytosis in Mouse Adrenal Chromaffin Cells by Prostaglandin EP3 Receptors
Mark L. Jewell et al.
MOLECULAR PHARMACOLOGY (2011)
Suppressed Accumulation of Cerebral Amyloid β Peptides in Aged Transgenic Alzheimer's Disease Mice by Transplantation with Wild-Type or Prostaglandin E2 Receptor Subtype 2-Null Bone Marrow
C. Dirk Keene et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Involvement of phosphoinositide 3-kinase γ in the neuro-inflammatory response and cognitive impairments induced by β-amyloid 1-40 peptide in mice
Giselle F. Passos et al.
BRAIN BEHAVIOR AND IMMUNITY (2010)
Atorvastatin prevents hippocampal cell death, neuroinflammation and oxidative stress following amyloid-β1-40 administration in mice: Evidence for dissociation between cognitive deficits and neuronal damage
Tetsade C. B. Piermartiri et al.
EXPERIMENTAL NEUROLOGY (2010)
The Prostaglandin E2 E-Prostanoid 4 Receptor Exerts Anti-Inflammatory Effects in Brain Innate Immunity
Ju Shi et al.
JOURNAL OF IMMUNOLOGY (2010)
Anti-amnesic effect of ESP-102 on Aβ1-42-induced memory impairment in mice
Dong Hyun Kim et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2010)
Emerging roles of PGE2 receptors in models of neurological disease
Katrin Andreasson
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2010)
Screening of innate immune receptors in neurodegenerative diseases: A similar pattern
Maryse Letiembre et al.
NEUROBIOLOGY OF AGING (2009)
The prostaglandin E2 EP2 receptor accelerates disease progression and inflammation in a model of amyotrophic lateral sclerosis
Xibin Liang et al.
ANNALS OF NEUROLOGY (2008)
Cognitive Function Over Time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT)
ARCHIVES OF NEUROLOGY (2008)
Age-related decrease in stimulated glutamate release and vesicular glutamate transporters in APP/PS1 transgenic and wild-type mice
R. Minkeviciene et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Protective effects of NSAIDs on the development of Alzheimer disease
Steven C. Vlad et al.
NEUROLOGY (2008)
Misoprostol, an anti-ulcer agent and PGE2 receptor agonist, protects against cerebral ischemia
Jun Li et al.
NEUROSCIENCE LETTERS (2008)
GABAA Receptor-Mediated Acceleration of Aging-Associated Memory Decline in APP/PS1 Mice and Its Pharmacological Treatment by Picrotoxin
Yuji Yoshiike et al.
PLOS ONE (2008)
Small Molecule, Non-Peptide p75NTR Ligands Inhibit Aβ-Induced Neurodegeneration and Synaptic Impairment
Tao Yang et al.
PLOS ONE (2008)
COX-2 inhibitors and cardiovascular risk
Colin D. Funk et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2007)
The increased activity of BACE1 correlates with oxidative stress in Alzheimer's disease
Roberta Borghi et al.
NEUROBIOLOGY OF AGING (2007)
Prostaglandin E2 receptor subtype 2 (EP2) regulates microglial activation and associated neurotoxicity induced by aggregated α-synuclein
Jinghua Jin et al.
JOURNAL OF NEUROINFLAMMATION (2007)
EP3 prostaglandin receptors in the median preoptic nucleus are critical for fever responses
Michael Lazarus et al.
NATURE NEUROSCIENCE (2007)
Role of the toll-like receptor 4 in neuro-inflammation in Alzheimer's disease
Silke Walter et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2007)
Long-term efficacy and safety of celecoxib in Alzheimer's disease
Hilkka Soininen et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2007)
Levels of CSF prostaglandin E-2, cognitive decline, and survival in Alzheimer's disease
M Combrinck et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2006)
Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer's disease in a sex-dimorphic pattern
T. Melnikova et al.
NEUROSCIENCE (2006)
Deletion of the prostaglandin E2 EP2 receptor reduces oxidative damage and amyloid burden in a model of Alzheimer's disease
XB Liang et al.
JOURNAL OF NEUROSCIENCE (2005)
A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment
LJ Thal et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Microglia lacking E prostanoid receptor subtype 2 have enhanced Aβ phagocytosis yet lack Aβ-activated neurotoxicity
FS Shie et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease:: Relationships to β-amyloid deposition and neurotransmitter abnormalities
A Savonenko et al.
NEUROBIOLOGY OF DISEASE (2005)
COX-2-derived prostacyclin confers atheroprotection on female mice
KM Egan et al.
SCIENCE (2004)
Aging-related increase in oxidative stress correlates with developmental pattern of beta-secretase activity and beta-amyloid plaque formation in transgenic Tg2576 mice with Alzheimer-like pathology
J Apelt et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2004)
Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review
CA Szekely et al.
NEUROEPIDEMIOLOGY (2004)
Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression - A randomized controlled trial
PS Aisen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease
LB Yang et al.
NATURE MEDICINE (2003)
Neuronal oxidative damage from activated innate immunity is EP2 receptor-dependent
TJ Montine et al.
JOURNAL OF NEUROCHEMISTRY (2002)
β-secretase protein and activity are increased in the neocortex in Alzheimer disease
H Fukumoto et al.
ARCHIVES OF NEUROLOGY (2002)
Oxidative stress increases expression and activity of BACE in NT2 neurons
E Tamagno et al.
NEUROBIOLOGY OF DISEASE (2002)
Increased expression of the amyloid precursor β-secretase in Alzheimer's disease
RMD Holsinger et al.
ANNALS OF NEUROLOGY (2002)
Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease
BA in 't Veld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity
S Weggen et al.
NATURE (2001)
Cyclooxygenase-independent actions of cyclooxygenase inhibitors
I Tegeder et al.
FASEB JOURNAL (2001)
Co-expression of multiple transgenes in mouse CNS: a comparison of strategies
JL Jankowsky et al.
BIOMOLECULAR ENGINEERING (2001)
Prostanoid receptors: Subtypes and signaling
RM Breyer et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2001)
Inflammation and Alzheimer's disease
H Akiyama et al.
NEUROBIOLOGY OF AGING (2000)
Share Paper
